The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in U.S. Primary Care Settings
Top Cited Papers
Open Access
- 21 February 2012
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 156 (4) , 263-270
- https://doi.org/10.7326/0003-4819-156-4-201202210-00378
Abstract
Hepatitis C virus (HCV) infection is most prevalent among adults born from 1945 through 1965, and most of them are currently undiagnosed. Whether screening based on birth cohort is more cost-effect... Background: In the United States, hepatitis C virus (HCV) infection is most prevalent among adults born from 1945 through 1965, and approximately 50% to 75% of infected adults are unaware of their ...Keywords
This publication has 60 references indexed in Scilit:
- Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from careHepatology, 2011
- Direct Economic Burden of Chronic Hepatitis C Virus in a United States Managed Care PopulationJournal of Clinical Gastroenterology, 2011
- Changing trends in hepatitis C–related mortality in the United States, 1995‐2004†‡Hepatology, 2007
- Natural History of Hepatitis CClinics in Liver Disease, 2005
- Mortality risk among new onset injection drug usersAddiction, 2004
- Diagnosis, management, and treatment of hepatitis C†Hepatology, 2004
- Cost-effectiveness of Treatment for Chronic Hepatitis C Infection in an Evolving Patient PopulationPublished by American Medical Association (AMA) ,2003
- Treatment of Chronic Hepatitis C in a State Correctional FacilityAnnals of Internal Medicine, 2003
- The association between knowledge of hepatitis C virus status and risk behaviors in injection drug usersAddiction, 2002
- Toward Consistency in Cost-Utility AnalysesMedical Care, 1998